| RS1555601006 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1555601009 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555601027 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555601059 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant tumor of breast, Breast-ovarian cancer |
| RS1555601064 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555601094 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555601203 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555601204 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555601234 |
GAA
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Glycogen storage disease |
| RS1555601255 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1555601409 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555601448 |
SCN4A
|
Health Risk |
Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1555601633 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555601662 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555601748 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555601754 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1555601780 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555601787 |
MKS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 13, Meckel syndrome |
| RS1555601802 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555601828 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555601863 |
UNC13D
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1555601979 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 12 |
| RS1555602080 |
JUP
|
Health Risk |
Likely pathogenic |
Naxos disease, Naxos disease |
| RS1555602124 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555602127 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1555602136 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555602141 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555602145 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555602149 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555602154 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555602158 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1555602159 |
RAD51C
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555602420 |
JUP
|
Health Risk |
Pathogenic |
Naxos disease, Arrhythmogenic right ventricular dysplasia 12 |
| RS1555602537 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555602638 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555602648 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555602692 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555602703 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555602832 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555602860 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555603011 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1555603048 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555603052 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555603056 |
RAD51C
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555603112 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1555603131 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555603132 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555603208 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555603216 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555603219 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555603264 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555603318 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555603364 |
SCN4A
|
Health Risk |
Likely pathogenic |
— |
| RS1555603434 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555603597 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1555603622 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555603635 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1555603638 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555603645 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555603671 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1555603752 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS1555603796 |
SLC25A19
|
Health Risk |
Pathogenic |
Progressive demyelinating neuropathy with bilateral striatal necrosis, Progressive demyelinating neuropathy with bilateral striatal necrosis |
| RS1555603894 |
KCNJ2
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1555603955 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Andersen Tawil syndrome, Andersen Tawil syndrome |
| RS1555603968 |
KCNJ2
|
Health Risk |
Likely pathogenic |
Andersen Tawil syndrome, Andersen Tawil syndrome |
| RS1555603974 |
KCNJ2
|
Health Risk |
Pathogenic |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS1555603994 |
KCNJ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Andersen Tawil syndrome |
| RS1555604462 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1555604481 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1555604541 |
SLC25A19
|
Health Risk |
Pathogenic |
Progressive demyelinating neuropathy with bilateral striatal necrosis, Progressive demyelinating neuropathy with bilateral striatal necrosis |
| RS1555604778 |
CLTC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS1555604867 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1555604874 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1555604877 |
NF1
|
Health Risk |
Pathogenic |
Spinal neurofibroma, Spinal neurofibroma |
| RS1555604887 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555604897 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555604899 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555604925 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555604935 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555604939 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555604941 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1555604942 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555605052 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS1555605054 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555605056 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS1555605068 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1555605074 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555605079 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS1555605096 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS1555605103 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555605347 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Familial meningioma |
| RS1555605362 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555605393 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555605396 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555605398 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1555605404 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555605406 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555605409 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555605497 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS1555605532 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |